Germitec, a leader in hospital hygiene solutions, has secured a significant financial boost with a €25 million investment from the European Investment Bank (EIB), facilitated by the InvestEU program. This strategic deal, announced Today, will accelerate the development of Germitec's advanced UV-C-based high-level disinfection (HLD) technology, which is critical in preventing cross-infection during ultrasound procedures.
The funding marks a pivotal moment for the 18-year-old company, enabling it to expand its innovative UV-C solutions for ultrasound probe disinfection globally. Vincent Gardès, CEO of Germitec, expressed his confidence in the technology's potential and the company's capacity for growth due to its market leadership. Ambroise Fayolle, EIB Vice-President, reiterated the EU's dedication to healthcare innovation, which is consistent with EIB’s mission and its substantial role during the COVID-19 crisis, also aligning with its status as the EU climate bank.
European Commissioner for Economy Paolo Gentiloni emphasized how such investments are crucial in maintaining Europe's leading position in the development of advanced medical technologies. The InvestEU program aims to mobilize over €372 billion (EUR1 = USD1.0857) in additional investment between 2021 and 2027 to support projects that are in line with EU policy objectives, building on the success of the previous Investment Plan for Europe.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.